< back to search

Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial.

Huang, Feng   •   Gu, Jieruo   •   Zhu, Ping   •   Bao, Chunde   •   Xu, Jianhua   •   Xu, Huji   •   Wu, Huaxiang   •   Wang, Guochun   •   Shi, Qun   •   Andhivarothai, Nupun   •   Anderson, Jaclyn   •   Pangan, Aileen L

published in: Annals of the rheumatic diseases



endpoint

Adalimumab has (optional: compared with placebo) proved to be better.
complication rate higher


basics

diagnosis:
ankylosing spondylitis

localization:
not specified

method:
conservative therapy → injection therapy
conservative therapy → injection

publication details

10.1136/annrheumdis-2012-202533
pubmed
23475983
2014
randomized controlled trial
yes
prospective
1+

▼
▲